WANG Jie, CHEN Zhi-yong. PhaseⅡStudy of Amrubicin as Second-Line Therapy in Patients with Platinum-Refractory Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2012, 12(1): 38-40. DOI: 10.3969/j.issn.1671-5144.2012.01.014
|
Citation:
|
WANG Jie, CHEN Zhi-yong. PhaseⅡStudy of Amrubicin as Second-Line Therapy in Patients with Platinum-Refractory Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2012, 12(1): 38-40. DOI: 10.3969/j.issn.1671-5144.2012.01.014
|
WANG Jie, CHEN Zhi-yong. PhaseⅡStudy of Amrubicin as Second-Line Therapy in Patients with Platinum-Refractory Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2012, 12(1): 38-40. DOI: 10.3969/j.issn.1671-5144.2012.01.014
|
Citation:
|
WANG Jie, CHEN Zhi-yong. PhaseⅡStudy of Amrubicin as Second-Line Therapy in Patients with Platinum-Refractory Small-Cell Lung Cancer[J]. Journal of Evidence-Based Medicine, 2012, 12(1): 38-40. DOI: 10.3969/j.issn.1671-5144.2012.01.014
|
DownLoad: